The School of Veterinary Medicine and The Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI 53706, USA.
Vet Comp Oncol. 2010 Mar;8(1):28-37. doi: 10.1111/j.1476-5829.2009.00200.x.
Standardized assessment of response to therapy for lymphoma in dogs is lacking, making critical comparisons of treatment protocols difficult. This Veterinary Cooperative Oncology Group (VCOG) consensus document, based on the recommendations of a subcommittee of ACVIM board-certified veterinary oncologists, was unanimously adopted at the 29th Annual Conference of the Veterinary Cancer Society (VCS) by the VCOG membership. It has integrated guidance from the response assessment criteria established for lymphoma in human patients using standards available in routine veterinary oncology practices that are simple, repeatable and consistently applicable. These guidelines are intended only for use in dogs, where peripheral lymphadenopathy represents the principal component of their disease and as such do not critically assess extranodal disease (e.g., primary cutaneous, central nervous system, gastrointestinal). It is hoped these guidelines will be widely adopted and serve to facilitate the comparison of current and future treatment protocols used in the therapy of dogs.
在犬淋巴瘤的治疗反应评估方面缺乏标准化,这使得治疗方案的关键比较变得困难。这份兽医肿瘤协作组(VCOG)的共识文件是根据 ACVIM 董事会认证兽医肿瘤学家小组委员会的建议制定的,在第 29 届兽医癌症协会(VCS)年会上得到了 VCOG 成员的一致通过。它整合了使用常规兽医肿瘤学实践中可用的标准为人类淋巴瘤患者制定的反应评估标准的指导意见,这些标准简单、可重复且适用。这些指南仅适用于外周淋巴结病是其疾病主要成分的犬,因此不严格评估结外疾病(例如原发性皮肤、中枢神经系统、胃肠道)。希望这些指南能够得到广泛采用,并有助于比较目前和未来用于治疗犬的治疗方案。